This approval provides patients with a new generic option for the folate analog metabolic inhibitor, which is used to treat various cancers and autoimmune conditions such as rheumatoid arthritis and ...

Alembic Pharmaceuticals Limited has received final approval from the U.S. Food and Drug Administration (FDA) for its ...

Alembic Pharmaceuticals receives USFDA approval for a generic methotrexate injection used in treating cancer and arthritis.

Alembic Pharmaceuticals advanced 2.35% to Rs 752.20 after the company announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug ...

Alembic Pharmaceuticals (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Methotrexate ...

Methotrexate Injection is used in the treatment of multiple conditions, including various cancers such as acute lymphoblastic ...

Alembic Pharmaceuticals' shares rose after receiving USFDA approval for its generic cancer treatment drug, Methotrexate ...

Alembic Pharmaceuticals receives USFDA approval for generic Methotrexate injection, used to treat cancers and arthritis. Read more here.

Alembic Pharmaceuticals secures USFDA approval for generic Methotrexate injection, boosting its oncology portfolio and strengthening its presence in the US generics market.